Posts Tagged: GlaxoSmithKline

News

State targets ‘bubble boy’ syndrome

Young David Vetter, who died from severe combined immunodeficiency (SCID) in the 1990s. (Photo: Biotechnology and Society)

California’s stem cell agency is ready to award $20 million on Thursday to a UCLA researcher to assist in his 30-year search for a widely available cure for what has come to be known as the “bubble boy” syndrome– severe combined immunodeficiency (SCID).

Support for Capitol Weekly is Provided by: